Financial Controversy Over Two Prison Contracts Gives Bibb Opponents Hope
Major banks have backed off of financing two of the three proposed new prisons in Alabama, leaving opponents of Gov. Kay Ivey’s plan to lease the prisons from private groups hopeful that any deals related to the third site, in Brierfield, also would hit a snag.
Bloomberg News reported Monday that the sudden about-face by Barclays and Keybanc took financial traders by surprise.
The prisons in Escambia and Elmore counties are slated to be built by CoreCivic, a prison company that has contracted with the state of Alabama to build the two prisons and lease them to the state for 30 years. The third site, proposed for Brierfield in Bibb County, is to be built and owned by a consortium headed by BL Harbert.
The banks’ sudden resignation as lead underwriters for the bond sale is considered highly unusual, as the debt was initially set to have been issued last week and pricing levels were already circulating among potential investors. According to a spokesperson for Barclays, the decision resulted from “feedback we have heard” from activists and concerned investors.
Chris Nelson, an activist in the prison opposition movement, said the group is hoping the Brierfield prison site runs into the same obstacles as the CoreCivic projects.
Nelson has been pursuing information about how the Brierfield prison will obtain water and sewer service by filing requests under the Freedom of Information Act with surrounding municipalities and water systems.
So far, he said, he has obtained letters confirming that Montevallo’s water board is willing to serve the prison with water and sewer — but only if the developers pay the cost of extending lines and upgrading the Montevallo sewage treatment plant.
Wilton, a town just south of Montevallo, has agreed to provide water to the prison in emergency situations only.
Meanwhile, other members of Nelson’s group, Alabama Students Against Prisons (ASAP), have gathered documents such as a report from the Ethical Investment Advisory Committee to the University of Rochester board of trustees warning that “it is unseemly at best for institutions of a free society to seek profits from investments in for-profit prisons.”
Another citation from ASAP was from a book by Lauren-Brooke Eisen “Inside Private Prisons: An American Dilemma in the Age of Mass Incarceration” about institutions interested in maintaining a favorable public image that are divesting from private prisons.
Several legislators have expressed dismay that Ivey went ahead with the prison deals without consulting the legislative branch.
Postal traffic to US drops more than 80% after trade exemption rule ends, UN agency says
The de minimis rule that allowed small packages worth less than $800 to be exempt from tariffs ended on Friday, Aug. 29, 2025.
Colombia’s lone Amazon port faces drying river and rising tensions with Peru
Colombia's only Amazon port town could soon be cut off from the river that keeps it alive. As drought and a shifting river spark a tense border dispute with Peru, locals are scrambling to adapt—and politicians are raising flags, literally.
Sunday Puzzle: Common denominator
NPR's Ayesha Rascoe plays the puzzle with Weekend Edition puzzlemaster Will Shortz along with listener Cynthia Rose of Littleton, Colorado.
South Korea says it has reached a deal with the US for the release of workers in a Georgia plant
More than 300 South Korean workers were detained in an immigration raid on Thursday. Presidential chief of staff Kang Hoon-sik said South Korea plans to send a charter plane to bring the workers home.
Hitch a ride to the moon in a rusty old car and ‘The Couch in the Yard’
As the sun sets in a small town, a family loads up their rusty old car with the spare couch in their yard. When it breaks down in the mountains, what else is there to do but fly it to the moon?
The silent killer increases your risk of stroke and dementia. Here’s how to control it
New recommendations for early treatment for hypertension to prevent strokes, heart attacks and dementia come as an experimental medication is shown to lower blood pressure in hard to treat patients.
